| Name | Title | Contact Details |
|---|---|---|
Kathy Weiler |
Executive Vice President, Chief Commercial and Growth Officer | Profile |
Debbi Bottomley |
VP of Marketing | Profile |
Jennifer Percy |
Director of Customer Success | Profile |
Daniel Schmidt |
Senior Sales Director | Profile |
Susan Worthy |
Chief Marketing Officer | Profile |
American Clinical Solutions is a leading provider of urine drug confirmation services, offering accurate testing for both prescription and illicit narcotics using the most advanced equipment available. Medical facilities and other healthcare providers rely on American Clinical to help ensure patient safety and maximize the benefits of prescription medicine use. ACS employs a unique, proprietary testing method with enhanced detection ability and improved accuracy which means physicians and other health care providers can prescribe with confidence. In addition to detecting improper use of prescribed and illicit drugs, ACS testing method helps healthcare providers monitor the efficacy of prescription regimens and alter the dosing scheme in response to changes in patient health status, behavior or other variables, helping patients achieve better outcomes while providing an overall greater level of safety. ACS techniques and technology were developed to meet or exceed the latest testing standards. Input from our physician colleagues provides invaluable guidance to help us refine our approach to ensure we continue to provide the best, most accurate testing results and reporting services available.
Definiti Healthcare Management (DBA) is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kannact is a human-driven digital health company that provides innovative healthcare collaboration solutions to improve the lives of patients with chronic conditions.
MSPCA is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Jamaica Plain, MA. To find more information about MSPCA, please visit www.mspca.org
Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.